Cytosorbents Corp
CTSO
38 hedge funds and large institutions have $8.69M invested in Cytosorbents Corp in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 6 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
6.26% more ownership
Funds ownership: 0% → 6.26% (+6.3%)
3% more funds holding
Funds holding: 37 → 38 (+1)
13% less capital invested
Capital invested by funds: $10M → $8.69M (-$1.35M)
39% less call options, than puts
Call options by funds: $95K | Put options by funds: $157K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$274K |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
+$171K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$94.5K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$83.2K |
| 5 |
Millennium Management
New York
|
+$71.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DWA
Douglass Winthrop Advisors
New York
|
-$451K |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$137K |
| 3 |
FAM
Fortaleza Asset Management
Chicago,
Illinois
|
-$110K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$106K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$68.6K |
CTSO Hedge Fund Activity: Q4 2016 in Review
38 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2016, worth a combined $8.69M — down 13% from $10M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CTSO positions and 6 closed out — a net gain of 1 holder — while 12 added to existing stakes and 8 trimmed.
The largest buyer was Manatuck Hill Partners, opening a new position worth an estimated $274K. The largest seller was Douglass Winthrop Advisors, exiting entirely with an estimated $451K sold.
- 38 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2016, up from 37 in Q3 2016.
- Funds reported $8.69M of Cytosorbents Corp stock for Q4 2016, down 13% quarter-over-quarter.
- 7 funds opened new Cytosorbents Corp positions in Q4 2016 and 6 closed out, a net change of +1 holder.
- The largest Cytosorbents Corp buyer in Q4 2016 was Manatuck Hill Partners, an estimated $274K added.
- The largest Cytosorbents Corp seller in Q4 2016 was Douglass Winthrop Advisors, an estimated $451K sold.
Based on aggregated 13F filings for Q4 2016.